Open access · US-GOV via ClinicalTrials.gov Clinical trial

Determination of a Minimal Clinically Important Difference of the "Functional Reach Test" in the Elderly.

Authors not listed

Pole Sante Grace de Dieu · 2023

Dysbiosis Human Randomized controlled trial

Abstract

The main objective of the study is to determine the Minimal Clinically Important Difference of the "Functional Reach Test" in the Elderly by a statistical method. The first secondary objective of the study is to determine the Minimal Clinically Important Difference by the Anchor method based on a qualitative assessment by the patients of their own response. The second secondary objective is to determine the Minimal Clinically Important Difference by the Delphi method, based on the search for a consensus between physiotherapists specializing in geriatrics.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-15 MST

Cite this

APA

Anonymous. (2023). Determination of a Minimal Clinically Important Difference of the "Functional Reach Test" in the Elderly. <em>Pole Sante Grace de Dieu</em>. https://clinicaltrials.gov/study/NCT05853406

Vancouver

Anonymous. Determination of a Minimal Clinically Important Difference of the "Functional Reach Test" in the Elderly. Pole Sante Grace de Dieu. 2023.

BibTeX

@misc{anon2023Determ, title = {Determination of a Minimal Clinically Important Difference of the "Functional Reach Test" in the Elderly.}, author = {Anonymous}, journal = {Pole Sante Grace de Dieu}, year = {2023}, }